NEW YORK, Nov. 17, 2017 /PRNewswire-USNewswire/ -- JDRF, the leading global organization funding type 1 diabetes (T1D) research, today announced that its Coverage2Control campaign swayed Anthem, America's second-largest health insurance
Growth Capitalist (https://growthcapitalist.com/2017/11/in-big-win-for-jdrfs-coverage2control-campaign-anthem-decides-to-cover-artificial-pancreas-systems/)
NEW YORK, Nov. 17, 2017 /PRNewswire-USNewswire/ -- JDRF, the leading global organization funding type 1 diabetes (T1D) research, today announced that its Coverage2Control campaign swayed Anthem, America's second-largest health insurance